Skip to main content

AVCR · Avricore Health Inc.

0.0500 CAD +0.0000 (+0.00%) At close · Nov 5 Intraday price with Plus

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Investor day
Close0.0500 CAD Open0.0450 CAD Day0.0450–0.0500 CAD 52W close0.0450–0.0900 CAD Avg vol 30d60K DataJan 2020–Nov 2026

Latest documents

2026
Nov 6
Annual report 20-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue 533.88K CAD ▼ 88.8% Net loss 1.86M CAD Diluted EPS -0.02 CAD
Oct 13
Current report 6-K
Current report

Avricore Health announced NHS England’s national expansion of the HealthTab™ cholesterol testing programme, with approximately 100 pharmacies across England offering seven-minute checks this fall through spring 2027.

All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 0.0450 CAD Now 0.0500 CAD · 11% Range high 0.0900 CAD
vs 200-day avg -18% vs 50-day avg -16%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XTSX:AVCR +0.0% -16.7% -33.3% +0.0% +0.0%

Exchange listing

Market
XTSX
Ticker
AVCR
ISIN
—
Security
Ordinary share
Trading currency
CAD

Company with tickers: AVCRF

Company

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Latest price

Plus & Pro

Follow AVCR during the session: the latest price, the day's change, range and volume. Closing prices stay free.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.